GlassScriptPhysician profile
Dixon L Freeman
NPI 1447237169
$1,088.28
in general payments reported to CMS, 2019-2025
17 companies · $26.82 in 2025
The $26.82 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $221 · 2021: $421 · 2022: $218 · 2023: $21.17 · 2025: $26.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.69 | 2019-2022 | |
| Pfizer INC. | $138.60 | 2020-2022 | |
| Daiichi Sankyo INC. | $112.25 | 2019-2022 | |
| Hologic Sales and Service, LLC | $93.50 | 2021-2023 | Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $49.23 | 2019-2020 | |
| Evofem Biosciences, INC. | $45.85 | 2022 | |
| Davol INC. | $42.35 | 2020-2021 | |
| Stryker Corporation | $30.38 | 2020 | |
| Organon LLC | $26.82 | 2025 | Jada System |
| Allergan, INC. | $26.77 | 2019 | |
| Caldera Medical, INC | $24.29 | 2021 | |
| Therapeuticsmd, INC. | $20.15 | 2020 | |
| Myovant Sciences INC. | $17.92 | 2021 | |
| Baxter Healthcare | $15.70 | 2022 | |
| Merck Sharp & Dohme LLC | $14.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $12.67 | 2019 | |
| Avion Pharmaceuticals | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dixon Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.